Screener
Achieve Life Sciences ACHV Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Achieve Life Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218177
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Change in fair value of contingent consideration [note 4 and note 5] | 285 | (91) |
| Other (expenses) income | (13) | 21 |
| Total other income | 295 | 67 |
| Net loss | $(10,168) | $(12,827) |
| OTHER COMPREHENSIVE LOSS | ||
| Net unrealized loss on marketable securities | (8) | (25) |
| Total other comprehensive loss | (8) | (25) |
| Comprehensive loss | $(10,176) | $(12,852) |
Item 1. Consolidated Financial Statements
FAQ
- What is Achieve Life Sciences's net income?
- Achieve Life Sciences (ACHV) reported net income of -$10.17M in Q1 2026.
- How has Achieve Life Sciences's net income changed year-over-year?
- Achieve Life Sciences's net income increased by 20.7% year-over-year, from -$12.83M to -$10.17M.
- What is the long-term trend for Achieve Life Sciences's net income?
- Over 4 years (2021 to 2025), Achieve Life Sciences's net income has grown at a 13.3% compound annual growth rate (CAGR), from -$33.15M to -$54.65M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Achieve Life Sciences's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude